Atlas Trials

Prospective Study to Evaluate Patient Reported Outcomes (PRO) During Rechallenge With Trabectedin in Sarcoma Patients

Clinical trial NCT06050434 · TERMINATED

Trial details

NCT number
NCT06050434
Sponsor
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Status
TERMINATED
Study type
OBSERVATIONAL
Soft Tissue Sarcoma
Start date
2023-10-31
Primary completion
2024-07-30
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.